| Patents for C07J 21 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton (1,576) |
|---|
| 12/30/2003 | CA2098146C Process for the preparation of 20-keto-21-alpha-hydroxy steroids and intermediates |
| 12/24/2003 | WO2003075015A3 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 12/18/2003 | US20030232981 Contacting a Delta 3,5-3-enol ether of formula (alkyl enol ether) with a hydride abstractor and an alcohol |
| 12/10/2003 | EP1368009A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 12/10/2003 | EP1077992B1 Use of meiosis regulating compounds |
| 12/03/2003 | CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives |
| 11/20/2003 | US20030216588 Purification of 7alpha-hydroxydehydroepiandrosterone and derivatives thereof and solvates obtained therefrom |
| 10/28/2003 | CA2077625C Preparation process of hydrocortisone and novel intermediates |
| 10/09/2003 | WO2003082895A2 Process to prepare eplerenone |
| 10/09/2003 | WO2003082894A2 C-17 spirolactonization and 6,7 oxidation of steroids |
| 10/09/2003 | CA2480151A1 C-17 spirolactonization and 6,7 oxidation of steroids |
| 10/09/2003 | CA2474072A1 Process to prepare eplerenone |
| 10/08/2003 | CN1446817A 7 alpha-hydroxy dehydroisoandrosterone and its derivative purifying process and obtained solvate |
| 10/07/2003 | US6630587 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 09/25/2003 | US20030181742 Process for the preparation of pregnane derivatives |
| 09/24/2003 | EP1346997A1 Process for the purification of 7-alpha-hydroxy-dehydroepiandrosteron and derivatives thereof, and solvates obtained |
| 09/16/2003 | US6620801 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 09/12/2003 | WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 09/12/2003 | WO2002009683A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 09/12/2003 | CA2478042A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 09/11/2003 | US20030171576 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone. |
| 09/10/2003 | EP1343013A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents. |
| 09/10/2003 | CN1120843C Isomerisation of equilin |
| 09/04/2003 | WO2002009760A9 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 09/03/2003 | EP1339734A2 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/03/2003 | EP1339733A2 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/03/2003 | EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 08/28/2003 | US20030162759 Preventing or treating cardiovascular disease including atherosclerosis |
| 08/26/2003 | US6610844 Removing an 11-alpha-leaving group from an epoxymexrenone derivative |
| 08/21/2003 | WO2003068736A2 Mixed steroidal 1,2,4,5-tetraoxane compounds and methods of making and using thereof |
| 08/20/2003 | EP1335928A1 Selective glucocorticoid receptor agonists |
| 07/22/2003 | US6596885 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions |
| 07/10/2003 | US20030130243 Hormone replacement therapy |
| 07/09/2003 | EP1325928A1 Process for the preparation of pregnane derivatives |
| 07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
| 07/03/2003 | WO2002094849A3 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 07/01/2003 | US6586591 Process for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 06/25/2003 | EP1321146A2 Inhibitors of type 5 and 3 17beta-hydroxysteroid dehydrogenase and methods for their use |
| 06/12/2003 | WO2002009683A9 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 06/04/2003 | EP0973790B1 Estra-5(10),7-dienes with estrogenic activity |
| 05/29/2003 | US20030100541 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 05/28/2003 | EP1313485A2 Use of an aldosterone receptor antagonist to improve cognitive function |
| 05/08/2003 | WO2002024715A3 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/02/2003 | EP0811006B1 Benzopyran-containing compounds and method for their use |
| 04/30/2003 | CN1107073C Supercritical fluid extraction process for extracting dioscin from Dioscorea plants |
| 04/23/2003 | EP1304333A2 6,7-Oxygenated steroids and uses related thereto |
| 04/23/2003 | EP1303308A2 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 04/23/2003 | EP1303306A2 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 04/17/2003 | US20030073675 Novel 19-norsteroids substituted in position 11beta, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them |
| 04/10/2003 | US20030069215 Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
| 04/08/2003 | CA2084431C 17-spirofuran-3'-ylidene steroids |
| 04/01/2003 | US6541463 Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use |
| 03/27/2003 | US20030060646 Process for preparing17alpha-acetoxy-11beta-[4-n,n(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene -3,20-dione, intermediates useful in the process , and processes for preparing such intermediates |
| 03/20/2003 | US20030055274 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 03/13/2003 | US20030050289 Combination of drospirenone and an estrogen sulphamate for HRT |
| 03/13/2003 | US20030050286 Steroids with a cyclohexene moiety are oxidized to the corresponding alpha, beta-unsaturated ketone that is converted to the corresponding vicinal diol using a hydroborating reagent followed by oxidative workup |
| 03/05/2003 | EP1288220A2 Neuroactive 3.alpha.-hydroxy-steroids of the androstane and pregnane series |
| 02/12/2003 | EP1032584B1 Novel 19-nor steroids substituted in position 11beta, preparation method and intermediates, application as medicines and pharmaceutical compositions containing them |
| 02/12/2003 | EP0863906B1 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 02/06/2003 | WO2002017895A3 Use of an aldosterone receptor antagonist to improve cognitive function |
| 02/05/2003 | EP1280533A2 Aldosterone antagonist composition for release during aldosterone acrophase |
| 01/23/2003 | WO2003006027A1 Combination of drospirenone and an estrogen sulphamate for hrt |
| 01/23/2003 | WO2002009760A3 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 01/20/2003 | WO2002020552A1 Process for the preparation of pregnane derivatives |
| 01/20/2003 | CA2416850A1 Process for the preparation of pregnane derivatives |
| 01/15/2003 | EP1274718A1 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group |
| 01/15/2003 | EP1274409A2 Antiprogestins with partial agonist activity |
| 01/15/2003 | EP0754178B1 Novel functionalized hydrophilic acridinium esters |
| 01/08/2003 | EP1272196A2 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 01/08/2003 | CN1389469A Separation and detection method of spironosaponin and furostsaponin |
| 01/07/2003 | CA2142303C Process for the production of 1-methyl-3-keto- steroids |
| 12/27/2002 | WO2002102391A2 Composition comprising nanoparticulate spironolactone |
| 12/19/2002 | WO2002100880A1 Method for preparing oestrogen derivatives |
| 12/11/2002 | CN1095847C New 17,20-epoxy derivatives of pregnane |
| 12/10/2002 | CA2084314C Starting compounds for the production of 10beta-h steroids and process for producing such starting compounds |
| 12/10/2002 | CA2084313C Process for the production of 10beta-h-steroids |
| 12/05/2002 | US20020183283 Meiosis regulating compounds |
| 12/04/2002 | EP0917534B1 6,7-oxygenated steroids and uses related thereto |
| 11/28/2002 | WO2002094849A2 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 11/28/2002 | WO2002009759A3 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 11/28/2002 | CA2447780A1 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 11/12/2002 | US6479476 Treating menopausal symptoms and osteoporosis in female warm-blooded animals |
| 10/15/2002 | CA2038985C Haloethyl-substituted steroidal enzyme inhibitors |
| 10/02/2002 | EP0944644B1 PROCESSES FOR PREPARATION OF 3-KETO-7alpha-ALKOXYCARBONYL-delta-4,5- STEROIDS AND INTERMEDIATES USEFUL THEREIN |
| 09/25/2002 | EP1242444A1 Process for preparing 17alpha-acetoxy-11beta- 4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 09/19/2002 | US20020132001 Delayed-release formulation of aldosterone antagonist drug which when orally administered 6-12 hours prior to acrophase provides profile of plasma drug concentration corresponding to diurnal cycle of plasma aldosterone concentration |
| 09/12/2002 | WO2002069977A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | WO2002038582A3 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/12/2002 | WO2002038581A3 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 09/12/2002 | CA2439687A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/05/2002 | US20020123485 For therapy of hypertension, cirrhosis and ascites |
| 08/28/2002 | EP1131336B1 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| 08/15/2002 | US20020111337 Use of an aldosterone receptor antagonist to improve cognitive function |
| 07/23/2002 | US6423698 Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia |
| 07/17/2002 | EP1223174A2 Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein |
| 06/27/2002 | WO2001072293A3 Antiprogestins with partial agonist activity |
| 06/18/2002 | US6407086 Novel sterol derivatives used for regulating the meiosis in oocytes and in male germ cells |
| 06/13/2002 | WO2001074839A3 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |